Inventor · disambiguated record
Serge Muyldermans
Also filed as: MUYLDERMANS SERGE · MUYLDERMANS SERGE VICTOR MARIE
11 granted patents·12 pending applications·32 citations·filing 1999–2024
86Inventor score
Files withUS GOV AIR FORCE7VLAAMS INTERUNIV INST BIOTECH4MUYLDERMANS SERGE3CENTRE NAT RECH SCIENT2UNIV BRUXELLES1
Top patents by PatentIndex Score
23 records- 0191US8097251B2Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereofMUYLDERMANS SERGE·Filed 2006·Granted Jan 17, 2012·22 cites·2 claims
- 0288US12344660B2Camelidae single-domain antibodies against Yersinia pestis and methods of useUS GOV AIR FORCE·Filed 2024·Granted Jul 1, 2025·0 cites·2 claims
- 0377US9156905B2Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereofMUYLDERMANS SERGE·Filed 2009·Granted Oct 13, 2015·2 cites·10 claims
- 0474US12030930B2Camelidae single-domain antibodies against Yersinia pestis and methods of useUS GOV AIR FORCE·Filed 2021·Granted Jul 9, 2024·0 cites·2 claims
- 0574US12030932B2Camelidae single-domain antibodies against Yersinia pestis and methods of useUS GOV AIR FORCE·Filed 2021·Granted Jul 9, 2024·0 cites·2 claims
- 0674US12030931B2Camelidae single-domain antibodies against Yersinia pestis and methods of useUS GOV AIR FORCE·Filed 2021·Granted Jul 9, 2024·0 cites·2 claims
- 0774US11987618B2Camelidae single-domain antibodies against Yersinia pestis and methods of useUS GOV AIR FORCE·Filed 2021·Granted May 21, 2024·0 cites·2 claims
- 0874US11891433B2Camelidae single-domain antibodies against Yersinia pestis and methods of useUS GOV AIR FORCE·Filed 2021·Granted Feb 6, 2024·0 cites·2 claims
- 0968US11339208B1Camelidae single-domain antibodies against Yersinia pestis and methods of useUS GOV AIR FORCE·Filed 2018·Granted May 24, 2022·0 cites·2 claims
- 1062US2025101133A1Development of nanobodies as first-in-class inhibitors for the deneddylating enzyme nedp1CENTRE NAT RECH SCIENT·Filed 2023·Application pending·0 cites
- 1155US2011251373A1Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereofVLAAMS INTERUNIV INST BIOTECH·Filed 2011·Application pending·0 cites
- 1255US2012172578A1Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereofMUYLDERMANS SERGE·Filed 2011·Application pending·0 cites
- 1354US2016052999A1Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereofVIB VZW·Filed 2015·Application pending·0 cites
- 1451US6479280B1Recombinant phages capable of entering host cells via specific interaction with an artificial receptorVLAAMS INTERUNIV INST BIOTECH·Filed 1999·Granted Nov 12, 2002·8 cites·10 claims
- 1551US2005054001A1Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereofFiled 2002·Application pending·0 cites
- 1651US2003148508A1Recombinant phages capable of entering host cells via specific interaction with an artificial receptorVLAAMS INTERUNIV INST BIOTECH·Filed 2002·Application pending·0 cites
- 1751US2007009527A1Method for cloning of variable domain sequencesVLAAMS INTERUNIV INST BIOTECH·Filed 2006·Application pending·0 cites
- 1849US2007031430A1ImmunoconjugatesUNIV BRUXELLES·Filed 2006·Application pending·0 cites
- 1949US2005048060A1ImmunoconjugatesFiled 2004·Application pending·0 cites
- 2046US2005037358A1Method for cloning of variable domain sequencesFiled 2002·Application pending·0 cites
- 2143US11453886B2Virus-like particles and uses thereofCENTRE NAT RECH SCIENT·Filed 2018·Granted Sep 27, 2022·0 cites·12 claims
- 2242US2004248201A1Recognition molecules interacting specifically with the active site or cleft of a target moleculeFiled 2003·Application pending·0 cites
- 2342US2003165877A1Recombinant phages capable of entering host cells via specific interaction with an artificial receptorFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Serge Muyldermans files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →